Figures
- FIGURE 1
Healthcare utilisation for patients with fibrosing interstitial lung diseases (ILDs) with a progressive phenotype. PF-ILD: progressive-fibrosing ILD.
Vol 27 Issue 150
Table of Contents
Healthcare utilisation and costs in the diagnosis and treatment of progressive-fibrosing interstitial lung diseases
Jump To
- Article
- Abstract
- Abstract
- Introduction
- Understanding the burden and assessing healthcare utilisation and costs of ILDs that may present a progressive fibrosing phenotype
- Domains of healthcare utilisation of ILDs that may present a progressive fibrosing phenotype: gaps and unmet needs
- Conclusions
- Acknowledgements
- Footnotes
- References
- Figures & Data
- Info & Metrics